NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

BRCAPAP: feasibility of clinical BRCA testing on liquid-based cervical cytology: implications for biomarker development.

Author(s): Muller CY, Schorge JO, Tomlinson GE, Ashfaq R

Publication: Cancer Epidemiol Biomarkers Prev, 2004, Vol. 13, Page 1534-7

PubMed ID: 15342457 PubMed Review Paper? No

Purpose of Paper

This paper compared BRCA genetic screening results among case-matched blood and cervical specimens to determine the degree of concordance.

Conclusion of Paper

A concordance of 100% was observed among blood, cervical, and vaginal specimens with respect to BRCA1 and 2 mutations and polymorphisms.

Studies

  1. Study Purpose

    This study compared BRCA genetic screening results among case-matched blood and cervical specimens to determine the degree of concordance.

    Summary of Findings:

    A concordance of 100% was observed among blood, cervical, and vaginal specimens with respect to BRCA1 and BRCA2 mutations and polymorphisms. Further, blood and cervical specimens generated DNA sequence of comparable quality.

    Biospecimens
    Preservative Types
    • Other Preservative
    Diagnoses:
    • Other diagnoses
    Platform:
    AnalyteTechnology Platform
    DNA DNA sequencing
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Biospecimen location Cervix
    Vagina
    Blood

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...